Genesis Vital Processors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -3.45%
- Profit Growth 3.83%
- Ebitda 7.57%
- Net Worth 13.81%
- Total Assets 7.79%
About Genesis Vital Processors
Genesis Vital Processors Private Limited (GVPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2007 and has a history of 17 years and ten months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Mahakh Medical Systems Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Richard Huber and Nerlekar Ajit serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72900PN2007PTC129850
-
Company No.
129850
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Mar 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Genesis Vital Processors?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nerlekar Ajit
|
Director | 14-Aug-2018 | Current |
Richard Huber
|
Director | 26-Mar-2007 | Current |
Financial Performance of Genesis Vital Processors.
Genesis Vital Processors Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.45% decrease. The company also saw a slight improvement in profitability, with a 3.83% increase in profit. The company's net worth Soared by an impressive increase of 13.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genesis Vital Processors?
In 2021, Genesis Vital Processors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genesis Vital Processors?
Genesis Vital Processors has a workforce of 18 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genesis Vital Processors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesis Vital Processors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
